[1]
“Antibody-Drug Conjugate in Cancer Therapy: Mechanism, Resistance, and Emerging Advances”, Int. J. of Res. in Pharmacology &Pharmacotherapeutics , vol. 14, no. 4, pp. 782–792, Oct. 2025, doi: 10.61096/ijrpp.v14.iss4.2025.782-792.